Omega Fund Management
Latest statistics and disclosures from Omega Fund Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are NUVB, REPL, IMGO, MORF, KRON, and represent 68.37% of Omega Fund Management's stock portfolio.
- Added to shares of these 2 stocks: Cincor Pharma (+$17M), THRX (+$8.2M).
- Started 2 new stock positions in THRX, Cincor Pharma.
- Reduced shares in these 10 stocks: NUVB (-$28M), ADGI (-$27M), AVIR (-$5.8M), MORF, CDTX, REPL, OBSV, PRTK, TRVI, GOSS.
- Sold out of its positions in ADGI, AVIR, CDTX, FGEN, TRVI, OBSV.
- Omega Fund Management was a net seller of stock by $-57M.
- Omega Fund Management has $489M in assets under management (AUM), dropping by -45.18%.
- Central Index Key (CIK): 0001637359
Tip: Access up to 7 years of quarterly data
Positions held by Omega Fund Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Omega Fund Management
Companies in the Omega Fund Management portfolio as of the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Nuvation Bio Class A Common Stock (NUVB) | 24.7 | $121M | -18% | 23M | 5.26 | |
| Replimune Group Common Stock (REPL) | 16.2 | $79M | -4% | 4.7M | 16.98 | |
| Imago Biosciences Common Stock (IMGO) | 11.9 | $58M | 3.0M | 19.27 | ||
| Morphic Holding Common Stock (MORF) | 9.9 | $48M | -8% | 1.2M | 40.15 | |
| Kronos Bio Common Stock (KRON) | 5.6 | $28M | 3.8M | 7.23 | ||
| Gossamer Bio Common Stock (GOSS) | 5.6 | $28M | -4% | 3.2M | 8.68 | |
| Immunic Common Stock (IMUX) | 4.1 | $20M | 1.8M | 11.30 | ||
| Alpine Immune Sciences Common Stock (ALPN) | 3.7 | $18M | 2.0M | 8.97 | ||
| Cincor Common Stock | 3.5 | $17M | NEW | 966k | 17.54 | |
| Ikena Oncology Common Stock (IKNA) | 2.8 | $14M | 2.2M | 6.10 | ||
| Arcutis Biothereapeutics Common Stock (ARQT) | 2.5 | $12M | 624k | 19.26 | ||
| Theseus Pharmaceuticals Common Stock (THRX) | 1.7 | $8.2M | NEW | 712k | 11.53 | |
| Sana Biotechnology Common Stock (SANA) | 1.4 | $7.0M | 844k | 8.26 | ||
| Paratek Pharmaceuticals Common Stock (PRTK) | 1.2 | $5.9M | -24% | 2.0M | 2.97 | |
Setup an alertOmega Fund Management will file the next quarterly 13-HR in about 3 months. Would you like to be notified? |
||||||
| Omega Alpha SPAC Class A Common Stock (OMEG) | 1.0 | $4.9M | 501k | 9.82 | ||
| Spruce Biosciences Common Stock (SPRB) | 0.9 | $4.3M | 2.2M | 2.01 | ||
| Checkmate Pharmaceuticals Common Stock (CMPI) | 0.9 | $4.3M | 1.3M | 3.19 | ||
| Icosavax Common Stock (ICVX) | 0.6 | $3.0M | 426k | 7.04 | ||
| Syros Pharmaceuticals Common Stock (SYRS) | 0.6 | $3.0M | 2.5M | 1.19 | ||
| ESSA Pharma Common Stock (EPIX) | 0.4 | $2.0M | 328k | 6.18 | ||
| Jounce Therapeutics Common Stock (JNCE) | 0.4 | $1.9M | 276k | 6.79 | ||
| Immunocore Holdings Common Stock (IMCR) | 0.3 | $1.5M | 52k | 29.90 | ||
Past Filings by Omega Fund Management
SEC 13F filings are viewable for Omega Fund Management going back to 2014
- Omega Fund Management 2022 Q1 filed May 13, 2022
- Omega Fund Management 2021 Q3 filed Nov. 15, 2021
- Omega Fund Management 2021 Q1 amended filed Nov. 15, 2021
- Omega Fund Management 2021 Q2 amended filed Nov. 15, 2021
- Omega Fund Management 2021 Q2 filed Aug. 16, 2021
- Omega Fund Management 2021 Q1 filed May 17, 2021
- Omega Fund Management 2020 Q4 filed Feb. 16, 2021
- Omega Fund Management 2020 Q3 filed Nov. 16, 2020
- Omega Fund Management 2020 Q2 filed Aug. 17, 2020
- Omega Fund Management 2020 Q1 filed May 14, 2020
- Omega Fund Management 2019 Q4 filed Feb. 13, 2020
- Omega Fund Management 2019 Q3 filed Nov. 13, 2019
- Omega Fund Management 2019 Q2 filed Aug. 13, 2019
- Omega Fund Management 2019 Q1 amended filed May 20, 2019
- Omega Fund Management 2019 Q1 filed May 15, 2019
- Omega Fund Management 2018 Q4 filed Feb. 11, 2019